id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-D-0610-0125,FDA,FDA-2025-D-0610,Development of Non-Opioid Analgesics for Chronic Pain; Guidance for Industry; Draft Guidance,Other,Guidance,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T15:19:21Z,,1,0,09000064b92d0c87
FDA-2025-D-0610-0001,FDA,FDA-2025-D-0610,"Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance for Industry; Availability",Notice,Notice of Availability,2025-09-11T04:00:00Z,2025,9,,,2025-09-11T19:01:24Z,2025-17442,0,0,09000064b8f6d13c
FDA-2025-D-0610-0002,FDA,FDA-2025-D-0610,Development of Non-Opioid Analgesics for Chronic Pain; Guidance for Industry; Draft Guidance,Other,Guidance,2025-09-11T04:00:00Z,2025,9,2025-09-11T04:00:00Z,2025-11-11T04:59:59Z,2025-12-11T10:00:26Z,,1,0,09000064b8f6bf9f